Jeena Sikho LifecareNSE:JSLL +3.81%91 Altman Z-Score is 24.79 as of Jun. 25, 2026, which is 30% below its 10-year median of 35.59. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.14 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 97.13% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 23.17 is strong.
Jeena Sikho Lifecare has a Altman Z-Score of 24.79, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Jeena Sikho Lifecare's Altman Z-Score or its related term are showing as below:
NSE:JSLL'
s Altman Z-Score Range Over the Past 10 Years
Min: 12.81 Med: 35.59 Max: 62.17
Current: 23.17
During the past 8 years, Jeena Sikho Lifecare's highest Altman Z-Score was 62.17. The lowest was 12.81. And the median was 35.59.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Jeena Sikho Lifecare Altman Z-Score Related Terms
Jeena Sikho Lifecare Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Jeena Sikho Lifecare's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.3498
+
1.4
*
0
+
3.3
*
0.4601
+
0.6
*
36.1135
+
1.0
*
1.1885
=
24.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Jeena Sikho Lifecare (NSE:JSLL) has a Altman Z-Score of 24.79 as of Jun. 25, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Jeena Sikho Lifecare and its competitors. This is 30% below median its historical median of 35.59. Over the past decade, Jeena Sikho Lifecare's Altman Z-Score has ranged from 12.81 to 62.17. According to the industry distribution chart, Jeena Sikho Lifecare ranks #19 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 2.9%.
Is Jeena Sikho Lifecare's Altman Z-Score too high?
Jeena Sikho Lifecare's current Altman Z-Score of 24.79 is 30% below median its 10-year median of 35.59. Over the past 10 years, this metric has ranged from a low of 12.81 to a high of 62.17. The Healthcare Providers & Services industry median Altman Z-Score is 2.37. Jeena Sikho Lifecare's value of 24.79 is 946% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #19 out of 661 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #19 out of 661 companies for Altman Z-Score. This places Jeena Sikho Lifecare in the top 3% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.37. Jeena Sikho Lifecare's value of 24.79 is 946% above this benchmark. Historically, Jeena Sikho Lifecare's own Altman Z-Score has ranged from 12.81 to 62.17 over the past decade. While the company's 10-year median is 35.59 vs. the industry median of 2.37, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.37, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current Altman Z-Score of 24.79 is 946% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current Altman Z-Score is 24.79, which is 30% below median its own 10-year median of 35.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.14, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current Altman Z-Score is 24.79, which is 30% below median its 10-year median of 35.59 and 946% above the Healthcare Providers & Services industry median of 2.37. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Altman Z-Score is 24.79 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.14.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
Altman Z-Score: 24.79 (30% below median its 10-year median of 35.59)
GF Value™: ₹771.14 vs. price of ₹602.25 (21.9% below fair value)
Industry Position: 946% above the Healthcare Providers & Services median (#19 of 661)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
